10,080 Shares in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Acquired by Envestnet Portfolio Solutions Inc.
Envestnet Portfolio Solutions Inc. bought a new position in Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Free Report) in the fourth quarter, HoldingsChannel.com reports. The fund bought 10,080 shares of the biotechnology company’s stock, valued at approximately $190,000. Other hedge funds have also added to or reduced their stakes in the company. HighTower Advisors LLC increased its […]
